Elodie Vauleon

Summary

Affiliation: Institut Paoli-Calmettes
Country: France

Publications

  1. ncbi DNA methylation in glioblastoma: impact on gene expression and clinical outcome
    Amandine Etcheverry
    CNRS UMR6061, Institut de Génétique et Développement, Universite de Rennes 1, Rennes, France
    BMC Genomics 11:701. 2010
  2. ncbi Usefulness of chemotherapy beyond the second line for metastatic breast cancer: a therapeutic challenge
    Elodie Vauleon
    Department of Medical Oncology, Comprehensive Cancer Center, E Marquis, CS 44229 Avenue de la Bataille Flandres Dunquerke, 35042, Rennes Cedex, France
    Cancer Chemother Pharmacol 66:113-20. 2010
  3. ncbi Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma
    Julien Edeline
    Department of Medical Oncology, Eugene Marquis Center, Rennes, France
    Cancer 118:147-56. 2012
  4. ncbi Cementoplasty for painful bone metastases: a series of 42 cases
    Estelle Botton
    Medical Oncology, Centre Eugene Marquis, avenue Bataille Flandres Dunkerque, 35042 Rennes Cedex, France
    Med Oncol 29:1378-83. 2012
  5. ncbi Impressive efficacy of sorafenib in a patient with an hepatocellular carcinoma and a portal vein thrombosis associated with a metastatic ENT cancer
    Catherine Leroux
    Department of Medical Oncology, Centre Eugene Marquis, CS 44229, 35042 Rennes Cedex, France
    Med Oncol 28:S246-9. 2011
  6. ncbi Immune genes are associated with human glioblastoma pathology and patient survival
    Elodie Vauleon
    Department of Medical Oncology, Eugène Marquis Cancer Institute, rue de la Bataille Flandres Dunkerque, Rennes 35042, France
    BMC Med Genomics 5:41. 2012
  7. ncbi [Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab]
    Elodie Vauleon
    Centre Eugene Marquis, Departement d Oncologie Medicale, CS 44229, 35042 Rennes Cedex, France, UMR 6061 CNRS, Universite de Rennes I, IFR 140, CS34317, 35043 Rennes Cedex, France
    Bull Cancer 99:121-6. 2012
  8. ncbi Tonsillar metastasis revealing signet-ring cell carcinoma of the rectum
    Elodie Vauleon
    Department of Medical Oncology, Comprehensive Cancer Center E Marquis, CS 44229, 35042 Rennes Cedex, France
    Gastroenterol Clin Biol 29:70-2. 2005
  9. ncbi Management of esophageal carcinoma associated with cirrhosis: a retrospective case-control analysis
    Florence Trivin
    Department of Medical Oncology, Centre Eugene Marquis, CS 44229, 35042 Rennes Cedex, France
    J Oncol 2009:173421. 2009
  10. ncbi Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: a retrospective study
    Julien Edeline
    Department of Medical Oncology, Centre E Marquis, 35042 Rennes Cedex, France
    World J Gastroenterol 15:713-6. 2009

Collaborators

Detail Information

Publications10

  1. ncbi DNA methylation in glioblastoma: impact on gene expression and clinical outcome
    Amandine Etcheverry
    CNRS UMR6061, Institut de Génétique et Développement, Universite de Rennes 1, Rennes, France
    BMC Genomics 11:701. 2010
    ..Genome-wide assessments of DNA methylation levels are now required to decipher the epigenetic events involved in the aggressive phenotype of glioblastoma, and to guide new treatment strategies...
  2. ncbi Usefulness of chemotherapy beyond the second line for metastatic breast cancer: a therapeutic challenge
    Elodie Vauleon
    Department of Medical Oncology, Comprehensive Cancer Center, E Marquis, CS 44229 Avenue de la Bataille Flandres Dunquerke, 35042, Rennes Cedex, France
    Cancer Chemother Pharmacol 66:113-20. 2010
    ..Several lines of chemotherapy can be proposed for patients with metastatic breast cancer, but beyond the second line, agreement is lacking concerning the most appropriate therapeutic strategy...
  3. ncbi Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma
    Julien Edeline
    Department of Medical Oncology, Eugene Marquis Center, Rennes, France
    Cancer 118:147-56. 2012
    ..In the current study, mRECIST were evaluated and were compared with RECIST in patients who received Sor for advanced HCC...
  4. ncbi Cementoplasty for painful bone metastases: a series of 42 cases
    Estelle Botton
    Medical Oncology, Centre Eugene Marquis, avenue Bataille Flandres Dunkerque, 35042 Rennes Cedex, France
    Med Oncol 29:1378-83. 2012
    ..Cementoplasty improves the quality of life of patients with bone metastases, by decreasing the pain in 88% of cases and allowing the resumption of walking in almost three-quarters of the patients who had lost the ability to walk...
  5. ncbi Impressive efficacy of sorafenib in a patient with an hepatocellular carcinoma and a portal vein thrombosis associated with a metastatic ENT cancer
    Catherine Leroux
    Department of Medical Oncology, Centre Eugene Marquis, CS 44229, 35042 Rennes Cedex, France
    Med Oncol 28:S246-9. 2011
    ..Tumor response of both cancers might suggest that sorafenib could be effective against head and neck cancer...
  6. ncbi Immune genes are associated with human glioblastoma pathology and patient survival
    Elodie Vauleon
    Department of Medical Oncology, Eugène Marquis Cancer Institute, rue de la Bataille Flandres Dunkerque, Rennes 35042, France
    BMC Med Genomics 5:41. 2012
    ..Several recent transcriptomic studies in GBM have identified different signatures involving immune genes associated with GBM pathology, overall survival (OS) or response to treatment...
  7. ncbi [Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab]
    Elodie Vauleon
    Centre Eugene Marquis, Departement d Oncologie Medicale, CS 44229, 35042 Rennes Cedex, France, UMR 6061 CNRS, Universite de Rennes I, IFR 140, CS34317, 35043 Rennes Cedex, France
    Bull Cancer 99:121-6. 2012
    ..5 months). The combination of irinotecan and bevacizumab appeared to provide clinical benefit to patients with recurrent GB...
  8. ncbi Tonsillar metastasis revealing signet-ring cell carcinoma of the rectum
    Elodie Vauleon
    Department of Medical Oncology, Comprehensive Cancer Center E Marquis, CS 44229, 35042 Rennes Cedex, France
    Gastroenterol Clin Biol 29:70-2. 2005
    ..Tonsil metastasis is rare and generally develops from primary gastric or colorectal cancer, predominantly poorly-differentiated or signet-ring cell adenocarcinomas...
  9. ncbi Management of esophageal carcinoma associated with cirrhosis: a retrospective case-control analysis
    Florence Trivin
    Department of Medical Oncology, Centre Eugene Marquis, CS 44229, 35042 Rennes Cedex, France
    J Oncol 2009:173421. 2009
    ....
  10. ncbi Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: a retrospective study
    Julien Edeline
    Department of Medical Oncology, Centre E Marquis, 35042 Rennes Cedex, France
    World J Gastroenterol 15:713-6. 2009
    ..To investigate the efficacy and toxicity of systemic chemotherapy in a retrospective study of patients with hepatocellular carcinoma (HCC) occurring in normal or fibrotic liver without cirrhosis...